DE3786806T2 - Reinigung von Keuchhustenantigenen. - Google Patents

Reinigung von Keuchhustenantigenen.

Info

Publication number
DE3786806T2
DE3786806T2 DE87300387T DE3786806T DE3786806T2 DE 3786806 T2 DE3786806 T2 DE 3786806T2 DE 87300387 T DE87300387 T DE 87300387T DE 3786806 T DE3786806 T DE 3786806T DE 3786806 T2 DE3786806 T2 DE 3786806T2
Authority
DE
Germany
Prior art keywords
lpf
produced
fha
purification
fimbrial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE87300387T
Other languages
English (en)
Other versions
DE3786806D1 (de
Inventor
Andrew Robinson
Lawrence Ian Irons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Protection Agency
Original Assignee
HEALTH LAB SERVICE BOARD
Public Health Laboratory Service Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEALTH LAB SERVICE BOARD, Public Health Laboratory Service Board filed Critical HEALTH LAB SERVICE BOARD
Publication of DE3786806D1 publication Critical patent/DE3786806D1/de
Application granted granted Critical
Publication of DE3786806T2 publication Critical patent/DE3786806T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE87300387T 1986-01-20 1987-01-16 Reinigung von Keuchhustenantigenen. Expired - Lifetime DE3786806T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868601279A GB8601279D0 (en) 1986-01-20 1986-01-20 Purification of pertussis antigens

Publications (2)

Publication Number Publication Date
DE3786806D1 DE3786806D1 (de) 1993-09-09
DE3786806T2 true DE3786806T2 (de) 1993-12-09

Family

ID=10591636

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87300387T Expired - Lifetime DE3786806T2 (de) 1986-01-20 1987-01-16 Reinigung von Keuchhustenantigenen.

Country Status (11)

Country Link
US (1) US4784589A (de)
EP (1) EP0231083B1 (de)
JP (1) JP2538224B2 (de)
KR (1) KR950010323B1 (de)
CN (1) CN1028206C (de)
AT (1) ATE92335T1 (de)
AU (1) AU592727B2 (de)
CA (1) CA1280693C (de)
DE (1) DE3786806T2 (de)
DK (1) DK172936B1 (de)
GB (1) GB8601279D0 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
CA1341123C (en) * 1988-10-27 2000-10-17 David A. Relman Filamentous hemagglutinin of b. pertussis
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5391715A (en) * 1989-11-06 1995-02-21 Smithkline Beecham Biologicals Method for isolating and purifying bordetella pertussis antigenic factors
DE69025375T2 (de) 1989-11-06 1996-08-01 Smithkline Beecham Biolog Verfahren
CY1935A (en) * 1990-02-12 1991-02-07 Smithkline Beecham Biolog Novel vaccine and method therefor
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US5445817A (en) * 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
WO1995029934A1 (en) * 1994-04-28 1995-11-09 Takeda Chemical Industries, Ltd. Method of separating protective components of bordetella pertussis
BR9608114A (pt) * 1995-05-04 2000-10-31 Connaught Lab Vacinas de pertussis a celular e processos para preparação das mesmas
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
MXPA05003057A (es) 2002-09-18 2006-04-18 Johnson & Johnson Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas.
MX362793B (es) 2013-03-08 2019-02-13 Janssen Vaccines & Prevention Bv Vacuna acelular contra pertussis.
CN110358802B (zh) * 2019-08-16 2021-06-18 长春百克生物科技股份公司 一种去除百日咳组分菌毛蛋白2/3内毒素的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4474758A (en) * 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
US4551429A (en) * 1983-09-15 1985-11-05 American Home Products Corporation Stimulation of antigen production by Bordetella pertussis
JPS6098988A (ja) * 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Ｌｐｆ−ｈａの精製法
CA1237998A (en) * 1984-04-14 1988-06-14 Akihiro Ginnaga Method for purification of filamentous hemagglutinin

Also Published As

Publication number Publication date
CN1028206C (zh) 1995-04-19
KR870006902A (ko) 1987-08-13
GB8601279D0 (en) 1986-02-26
DE3786806D1 (de) 1993-09-09
ATE92335T1 (de) 1993-08-15
EP0231083A3 (en) 1988-06-08
AU6766487A (en) 1987-07-23
EP0231083A2 (de) 1987-08-05
DK172936B1 (da) 1999-10-11
US4784589A (en) 1988-11-15
CA1280693C (en) 1991-02-26
EP0231083B1 (de) 1993-08-04
JPS62234031A (ja) 1987-10-14
KR950010323B1 (ko) 1995-09-14
AU592727B2 (en) 1990-01-18
CN87100399A (zh) 1987-09-09
JP2538224B2 (ja) 1996-09-25
DK27287D0 (da) 1987-01-19
DK27287A (da) 1987-07-21

Similar Documents

Publication Publication Date Title
DE3786806T2 (de) Reinigung von Keuchhustenantigenen.
MX9708481A (es) Vacunas acelulares de pertussis y metodos de preparacion de las mismas.
DK496485A (da) Transformation af gaer-stammer af slaegten pichia
ATE107535T1 (de) Gaschromatographische methode zur trennung von wasserstoffisotopen.
ES8202058A1 (es) Metodo de producir toxoide de pertussis
DK0522291T3 (da) Fremgangsmåde til rensning af hepatitis A-virus (HAV), således renset virus og vaccinepræparater indeholdende dette
ATE97448T1 (de) Verfahren zur isolierung von ca 125-antigen.
ATE47820T1 (de) Verfahren zur reinigung von abwasser.
AU2352595A (en) Method of separating protective components of bordetella pertussis
ZA908801B (en) Process for purifying antigenic factors from b.pertussis
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
ATE2339T1 (de) Verfahren zur herstellung von sphingomyelinase, sphingomyelinase und deren verwendung.
JPS5464683A (en) Preparation of unicellular protein
DK0408742T3 (da) Fremgangsmåde til fremstilling og rensning af hepatitis B vaccine
JPS5750892A (en) Microbial preparation of valeric acid derivative
DK222887A (da) Fremgangsmaade til fremstilling af l-aminosyrer ved fermentering af alfa-ketocarboxylsyrer
DE3750330D1 (de) Verfahren zur Herstellung eines Impfstoffs gegen Hepatitis B.
JPS5539730A (en) Preparation of ubiquinone q10

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MICROBIOLOGICAL RESEARCH AUTHORITY, SALISBURY, GB

8327 Change in the person/name/address of the patent owner

Owner name: HEALTH PROTECTION AGENCY, SALISBURY, WILTSHIRE, GB